874 — Guangzhou Baiyunshan Pharmaceutical Holdings Co Income Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedMicro Cap
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 64,952 | 61,674 | 69,014 | 70,788 | 75,515 |
Cost of Revenue | |||||
Gross Profit | 12,859 | 10,416 | 13,221 | 13,272 | 14,185 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 60,899 | 58,004 | 64,231 | 65,718 | 70,393 |
Operating Profit | 4,053 | 3,670 | 4,783 | 5,070 | 5,122 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,129 | 3,739 | 4,723 | 5,043 | 5,110 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,441 | 3,092 | 3,969 | 4,253 | 4,259 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3,189 | 2,915 | 3,720 | 3,967 | 4,056 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,189 | 2,915 | 3,720 | 3,967 | 4,056 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.97 | 1.8 | 2.27 | 2.43 | 2.48 |
Dividends per Share |